Competition Doesn’t Slow Cancer Drug Price Increases

New research shows the average price increase for cancer drugs has risen 37 percent over 12 years. Research costs and high demand are among the reasons.

Copyright Disclaimer:This article has been RSS syndicated and was originally published here.